Multiple Myeloma clinical trials in Australia
44 multiple myeloma trials recruiting in Australia
Multiple myeloma is a blood cancer affecting plasma cells. Areas of active research include bispecific antibodies, CAR-T cell therapy, and novel drug combinations for newly diagnosed and relapsed myeloma.
Describe the diagnosis below and we'll find matching trials.
For information only. Matches are AI generated. Always consult your healthcare team prior to any medical decisions.
Three steps. About 30 seconds.
Describe
Tell us about your multiple myeloma in your own words, or use the step-by-step form. Even rough detail works.
Match
We search actively recruiting multiple myeloma trials in Australia and explain why each may be relevant to you.
Discuss
Get clear summaries of each trial and questions to ask your doctor. Print or save the results to take to your next appointment.
Multiple Myeloma clinical trials: common questions
The things people most often ask about multiple myeloma trials.
Multiple myeloma is a cancer of plasma cells, a type of white blood cell that normally produces antibodies as part of the immune system. In myeloma, abnormal plasma cells build up in the bone marrow and produce abnormal proteins that can damage bone, kidneys, and the immune system. Because the cancer is spread through the bone marrow rather than forming a single tumour, treatment and research focus on systemic therapies that travel through the bloodstream.
The information above is general in nature. Always discuss specific trial options and treatment decisions with your oncologist or treating team.
Search other cancer types
TrialLight covers over 25 cancer types across Australia.